SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma informs about change of name of RTA

12 Dec 2019 Evaluate

Aurobindo Pharma has informed that the Company has been informed by its Registrar & Transfer Agent (RTA) that its name has been changed from Karvy Fintech to KFin Technologies with effect from December 05, 2019. It requests to take note of the above name change and update the same in records. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1406.60 15.45 (1.11%)
22-Apr-2026 12:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.60
Dr. Reddys Lab 1220.35
Cipla 1233.90
Zydus Lifesciences 931.50
Lupin 2308.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×